NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 298 filers reported holding NEOGENOMICS INC in Q3 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,753,521 | -23.3% | 2,987,920 | +0.3% | 0.01% | -20.0% |
| Q2 2023 | $47,894,554 | +2.2% | 2,980,374 | +10.7% | 0.02% | -6.2% |
| Q1 2023 | $46,879,591 | +283228.8% | 2,692,607 | +50.4% | 0.02% | +220.0% |
| Q4 2022 | $16,546 | -99.8% | 1,790,583 | +83.9% | 0.01% | +66.7% |
| Q3 2022 | $8,385,000 | -16.0% | 973,871 | -20.4% | 0.00% | -25.0% |
| Q2 2022 | $9,977,000 | -42.0% | 1,224,174 | -13.5% | 0.00% | -20.0% |
| Q1 2022 | $17,207,000 | -67.2% | 1,415,978 | -7.8% | 0.01% | -68.8% |
| Q4 2021 | $52,403,000 | -21.4% | 1,535,856 | +11.2% | 0.02% | -23.8% |
| Q3 2021 | $66,630,000 | +38.2% | 1,381,165 | +29.4% | 0.02% | +40.0% |
| Q2 2021 | $48,203,000 | +8.5% | 1,067,071 | +15.9% | 0.02% | 0.0% |
| Q1 2021 | $44,437,000 | -30.9% | 920,316 | -22.9% | 0.02% | -34.8% |
| Q4 2020 | $64,297,000 | +33.2% | 1,194,199 | -8.7% | 0.02% | +15.0% |
| Q3 2020 | $48,256,000 | +14.3% | 1,308,117 | -4.1% | 0.02% | +5.3% |
| Q2 2020 | $42,230,000 | -2.6% | 1,363,360 | -13.2% | 0.02% | -17.4% |
| Q1 2020 | $43,366,000 | +1.2% | 1,570,678 | +7.2% | 0.02% | +43.8% |
| Q4 2019 | $42,840,000 | +53.5% | 1,464,633 | +0.4% | 0.02% | +45.5% |
| Q3 2019 | $27,905,000 | -9.4% | 1,459,486 | +4.0% | 0.01% | -8.3% |
| Q2 2019 | $30,793,000 | +19.3% | 1,403,565 | +11.2% | 0.01% | +20.0% |
| Q1 2019 | $25,821,000 | +79.9% | 1,262,157 | +10.9% | 0.01% | +42.9% |
| Q4 2018 | $14,352,000 | -3.2% | 1,138,241 | +17.9% | 0.01% | +16.7% |
| Q3 2018 | $14,825,000 | +50.2% | 965,790 | +28.3% | 0.01% | +50.0% |
| Q2 2018 | $9,870,000 | +105.9% | 752,853 | +28.2% | 0.00% | +100.0% |
| Q1 2018 | $4,793,000 | -9.1% | 587,402 | -1.3% | 0.00% | 0.0% |
| Q4 2017 | $5,271,000 | -21.4% | 594,883 | -1.3% | 0.00% | -33.3% |
| Q3 2017 | $6,709,000 | +15.4% | 602,806 | -7.1% | 0.00% | 0.0% |
| Q2 2017 | $5,816,000 | +82.2% | 649,060 | +60.4% | 0.00% | +50.0% |
| Q1 2017 | $3,192,000 | +151.1% | 404,626 | +172.8% | 0.00% | +100.0% |
| Q4 2016 | $1,271,000 | – | 148,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |